Is Fidelity High Dividend ETF a Good Investment Now?
Fidelity’s High Dividend ETF (FDVV) is a fund that offers…
Sell
27
ELV Quote, Financials, Valuation and Earnings
Last price:
$429.13
Seasonality move
:
4.85%
Day range:
$428.47 - $458.73
52-week range:
$362.21 - $567.26
Dividend yield:
1.54%
P/E ratio:
16.75x
P/S ratio:
0.56x
P/B ratio:
2.36x
Volume:
4.5M
Avg. volume:
1.8M
1-year change:
-13.98%
Market cap:
$97.5B
Revenue:
$176.8B
EPS (TTM):
$25.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$46.2B | $11.10 | 8.66% | 12.94% | $498.18 |
|
CI
The Cigna Group
|
$60.4B | $6.35 | 8.98% | 124.09% | $362.55 |
|
CNC
Centene
|
$43.1B | $2.42 | 6.82% | 8.96% | $78.62 |
|
CVS
CVS Health
|
$93.1B | $1.62 | 5.24% | 83.69% | $72.26 |
|
MOH
Molina Healthcare
|
$10.9B | $5.97 | 9.4% | 16.06% | $338.46 |
|
UNH
UnitedHealth Group
|
$111.6B | $7.31 | 11.83% | 15.56% | $628.30 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$428.89 | $498.18 | $97.5B | 16.75x | $1.71 | 1.54% | 0.56x |
|
CI
The Cigna Group
|
$322.40 | $362.55 | $88.2B | 26.34x | $1.51 | 1.77% | 0.37x |
|
CNC
Centene
|
$61.93 | $78.62 | $30.7B | 9.92x | $0.00 | 0% | 0.20x |
|
CVS
CVS Health
|
$63.66 | $72.26 | $80.3B | 17.39x | $0.67 | 4.18% | 0.22x |
|
MOH
Molina Healthcare
|
$346.71 | $338.46 | $19.2B | 16.97x | $0.00 | 0% | 0.49x |
|
UNH
UnitedHealth Group
|
$525.05 | $628.30 | $480.3B | 33.87x | $2.10 | 1.6% | 1.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ELV
Elevance Health
|
43.05% | 0.106 | 37.17% | 2.01x |
|
CI
The Cigna Group
|
43.79% | 0.375 | 42.17% | 0.77x |
|
CNC
Centene
|
41.24% | 0.128 | 61.49% | 1.06x |
|
CVS
CVS Health
|
46.73% | 1.052 | 116.81% | 0.56x |
|
MOH
Molina Healthcare
|
39.4% | -0.134 | 17.93% | 1.56x |
|
UNH
UnitedHealth Group
|
45.36% | 0.784 | 16.27% | 0.75x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
-- | -- | 8.66% | 14.4% | 2.08% | $384M |
|
CI
The Cigna Group
|
-- | -- | 4.6% | 8.07% | 3.61% | $4.9B |
|
CNC
Centene
|
$3.7B | $175M | 7.38% | 12.3% | 1.27% | -$741M |
|
CVS
CVS Health
|
$12.9B | $2.5B | 3.29% | 6.12% | 2.95% | $1.1B |
|
MOH
Molina Healthcare
|
$1.1B | $380M | 17.03% | 25.84% | 3.62% | -$235M |
|
UNH
UnitedHealth Group
|
$21.3B | $7.8B | 8.3% | 14.34% | 7.73% | $1.5B |
Elevance Health vs. Competitors
-
Which has Higher Returns ELV or CI?
The Cigna Group has a net margin of 0.92% compared to Elevance Health's net margin of 2.17%. Elevance Health's return on equity of 14.4% beat The Cigna Group's return on equity of 8.07%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CIThe Cigna Group-- $5.13 $73.2B -
What do Analysts Say About ELV or CI?
Elevance Health has a consensus price target of $498.18, signalling upside risk potential of 16.16%. On the other hand The Cigna Group has an analysts' consensus of $362.55 which suggests that it could grow by 12.45%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CIThe Cigna Group13 7 0 -
Is ELV or CI More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.385%.
-
Which is a Better Dividend Stock ELV or CI?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.54%. The Cigna Group offers a yield of 1.77% to investors and pays a quarterly dividend of $1.51 per share. Elevance Health pays 25.22% of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CI?
Elevance Health quarterly revenues are $45.4B, which are smaller than The Cigna Group quarterly revenues of $65.7B. Elevance Health's net income of $418M is lower than The Cigna Group's net income of $1.4B. Notably, Elevance Health's price-to-earnings ratio is 16.75x while The Cigna Group's PE ratio is 26.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.56x versus 0.37x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.56x 16.75x $45.4B $418M CIThe Cigna Group0.37x 26.34x $65.7B $1.4B
-
Which has Higher Returns ELV or CNC?
Centene has a net margin of 0.92% compared to Elevance Health's net margin of 0.69%. Elevance Health's return on equity of 14.4% beat Centene's return on equity of 12.3%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CNCCentene9.12% $0.56 $45B -
What do Analysts Say About ELV or CNC?
Elevance Health has a consensus price target of $498.18, signalling upside risk potential of 16.16%. On the other hand Centene has an analysts' consensus of $78.62 which suggests that it could grow by 26.96%. Given that Centene has higher upside potential than Elevance Health, analysts believe Centene is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CNCCentene7 7 1 -
Is ELV or CNC More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.
-
Which is a Better Dividend Stock ELV or CNC?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.54%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CNC?
Elevance Health quarterly revenues are $45.4B, which are larger than Centene quarterly revenues of $40.8B. Elevance Health's net income of $418M is higher than Centene's net income of $283M. Notably, Elevance Health's price-to-earnings ratio is 16.75x while Centene's PE ratio is 9.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.56x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.56x 16.75x $45.4B $418M CNCCentene0.20x 9.92x $40.8B $283M
-
Which has Higher Returns ELV or CVS?
CVS Health has a net margin of 0.92% compared to Elevance Health's net margin of 1.68%. Elevance Health's return on equity of 14.4% beat CVS Health's return on equity of 6.12%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CVSCVS Health13.2% $1.30 $142B -
What do Analysts Say About ELV or CVS?
Elevance Health has a consensus price target of $498.18, signalling upside risk potential of 16.16%. On the other hand CVS Health has an analysts' consensus of $72.26 which suggests that it could grow by 13.51%. Given that Elevance Health has higher upside potential than CVS Health, analysts believe Elevance Health is more attractive than CVS Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 CVSCVS Health12 9 0 -
Is ELV or CVS More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.622%.
-
Which is a Better Dividend Stock ELV or CVS?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.54%. CVS Health offers a yield of 4.18% to investors and pays a quarterly dividend of $0.67 per share. Elevance Health pays 25.22% of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CVS?
Elevance Health quarterly revenues are $45.4B, which are smaller than CVS Health quarterly revenues of $97.7B. Elevance Health's net income of $418M is lower than CVS Health's net income of $1.6B. Notably, Elevance Health's price-to-earnings ratio is 16.75x while CVS Health's PE ratio is 17.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.56x versus 0.22x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.56x 16.75x $45.4B $418M CVSCVS Health0.22x 17.39x $97.7B $1.6B
-
Which has Higher Returns ELV or MOH?
Molina Healthcare has a net margin of 0.92% compared to Elevance Health's net margin of 2.39%. Elevance Health's return on equity of 14.4% beat Molina Healthcare's return on equity of 25.84%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B MOHMolina Healthcare10.6% $4.44 $7.4B -
What do Analysts Say About ELV or MOH?
Elevance Health has a consensus price target of $498.18, signalling upside risk potential of 16.16%. On the other hand Molina Healthcare has an analysts' consensus of $338.46 which suggests that it could fall by -2.38%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 MOHMolina Healthcare6 7 0 -
Is ELV or MOH More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.
-
Which is a Better Dividend Stock ELV or MOH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.54%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or MOH?
Elevance Health quarterly revenues are $45.4B, which are larger than Molina Healthcare quarterly revenues of $10.5B. Elevance Health's net income of $418M is higher than Molina Healthcare's net income of $251M. Notably, Elevance Health's price-to-earnings ratio is 16.75x while Molina Healthcare's PE ratio is 16.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.56x versus 0.49x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.56x 16.75x $45.4B $418M MOHMolina Healthcare0.49x 16.97x $10.5B $251M
-
Which has Higher Returns ELV or UNH?
UnitedHealth Group has a net margin of 0.92% compared to Elevance Health's net margin of 5.5%. Elevance Health's return on equity of 14.4% beat UnitedHealth Group's return on equity of 14.34%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B UNHUnitedHealth Group21.14% $5.98 $179.5B -
What do Analysts Say About ELV or UNH?
Elevance Health has a consensus price target of $498.18, signalling upside risk potential of 16.16%. On the other hand UnitedHealth Group has an analysts' consensus of $628.30 which suggests that it could grow by 19.67%. Given that UnitedHealth Group has higher upside potential than Elevance Health, analysts believe UnitedHealth Group is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health13 4 0 UNHUnitedHealth Group21 0 0 -
Is ELV or UNH More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.
-
Which is a Better Dividend Stock ELV or UNH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.54%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 25.22% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or UNH?
Elevance Health quarterly revenues are $45.4B, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. Elevance Health's net income of $418M is lower than UnitedHealth Group's net income of $5.5B. Notably, Elevance Health's price-to-earnings ratio is 16.75x while UnitedHealth Group's PE ratio is 33.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.56x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.56x 16.75x $45.4B $418M UNHUnitedHealth Group1.22x 33.87x $100.8B $5.5B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kinder Morgan Dividend Yield Worth It?
Kinder Morgan (NYSE:KMI) is a major energy infrastructure company in…
What Is the Best ETF to Buy This Year?
The stock market has gotten off to an extremely rough…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 5
Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.
Sell
25
GDXU alert for Apr 5
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.
Buy
76
SOXS alert for Apr 5
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.
